Ginkgo Biloba vs Huperzine a for focus
Short answer: For focus, users rate them about the same: 84% report improvement with Ginkgo Biloba (61 reports) and 88% with Huperzine a (48 reports).
Ginkgo Biloba has 207 meta-analyses and 284 randomized trials on PubMed; Huperzine a has 18 and 14.
Based on 390 reports about Ginkgo Biloba and 301 about Huperzine a. Not medical advice.
| Ginkgo Biloba Supplement | Huperzine a Supplement | |
|---|---|---|
| Users say it helped | 52%helped121 reports · high confidence | 56%helped96 reports · medium confidence |
| Verdict | Mixed | Mixed |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 207 / 284 | 18 / 14 |
| Mainly used for | ||
| Focus % reporting improvement | 84% (61) | 88% (48) |
| Memory % reporting improvement | 90% (30) | 89% (46) |
| Mood % reporting improvement | 85% (13) | 60% (5) |
| Anxiety % reporting improvement | 83% (12) | 60% (5) |
| Energy % reporting improvement | 83% (6) | 100% (9) |
| Common side effects | headache, stomach issues, part of, weak ache | vivid dreams, nausea, sweating, dizziness |
| Typical dose reported | 240 mg / daily | 200 mcg / 2x |
EGb761 at 240 mg/day is able to stabilize or slow decline in cognition, function, behavior, and global change at 22-26 weeks in cognitive impairment and dementia, especially for patients with neuropsychiatric symptoms.
J Alzheimers Dis, 2015 ↗“I've been able to notice a difference from taking (caffeine pills, Ginko Biloba pills, etc)”
This review suggests that adjunctive HupA is an effective choice for improving cognitive function for patients with schizophrenia spectrum disorders. More well-designed RCTs are needed to further confirm HupA's efficacy. Copyright © 2016 John Wiley & Sons, Ltd.
Hum Psychopharmacol, 2016 ↗“Huperzine a 250mcg a day fixed my dad right up. It's actually the same med and dosage used in China for dementia.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate